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Abstract
Many studies have shown that cigarette smoking exerts multiple effects on the thyroid gland. Smoking seems to induce changes in thyroid 
function tests, like decrease in TSH and increase in thyroid hormones. However, these alterations are usually mild. In addition, tobacco 
smoking may also play a role in thyroid autoimmunity. Many studies have confirmed a significant influence of smoking on Graves’ 
hyperthyroidism and particularly on Graves’ orbitopathy. Here, smoking may increase the risk of disease development, may reduce the 
effectiveness of treatment, and eventually induce relapse. The role of smoking in Hashimoto’s thyroiditis is not as well established as 
in Graves’ disease. Nonetheless, lower prevalence of thyroglobulin antibodies, thyroperoxidase antibiodies and hypothyroidism were 
found in smokers. These findings contrast with a study that reported increased risk of hypothyroidism in smokers with Hashimoto’s 
thyroiditis. Moreover, cigarette smoking increases the incidence of multinodular goitre, especially in iodine-deficient areas. Some studies 
have examined cigarette smoking in relation to the risk of thyroid cancer. Interestingly, many of them have shown that smoking may 
reduce the risk of differentiated thyroid cancer. Furthermore, both active and passive smoking during pregnancy might modify maternal 
and foetal thyroid function. 
This review evaluates the current data concerning the influence of cigarette smoking on thyroid gland, including hormonal changes, 
autoimmunity and selected diseases. These findings, however, in our opinion, should be carefully evaluated and some of them are not 
totally evidence-based. Further studies are required to explain the effects of smoking upon thyroid pathophysiology. 
(Endokrynol Pol 2014; 65 (1): 54–62)
Key words: thyroid; smoking; tobacco; nicotine; thyroid hormones; TSH; TSH receptor autoantibodies; Graves’ disease; Hashimoto’s thyroiditis; 
postpartum thyroiditis
Streszczenie
Wyniki wielu badań dowodzą, że palenie papierosów wywiera istotny wpływ na gruczoł tarczowy. Wykazano, że nikotynizm mody-
fikuje parametry hormonalne tarczycy, w szczególności prowadzi do obniżenia stężenia TSH. Sugeruje się, że może również powodować 
nieznaczny wzrost stężenia wolnych hormonów tarczycy. Ponadto, palenie papierosów odgrywa istotną rolę w procesach autoimmu-
nologicznych związanych z gruczołem tarczowym. Dowiedziono, że nikotynizm wywiera negatywny wpływ na przebieg choroby 
Gravesa i Basedowa oraz orbitopatii Gravesa i Basedowa. Palenie papierosów nie tylko zwiększa ryzyko rozwoju powyższych schorzeń, 
ale zmniejsza również skuteczność terapii i zwiększa ryzyko nawrotu. Wpływ palenia papierosów na chorobę Hashimoto nie jest tak 
jednoznacznie dowiedziony, jak w chorobie Gravesa i Basedowa. Sugeruje się, że palenie papierosów może negatywnie korelować 
z mianem przeciwciał przeciwko tyreoglobulinie oraz tyreoperoksydazie, zmniejszając w konsekwencji ryzyko rozwoju hipotyreozy. 
Palenie papierosów zwiększa ryzyko wystąpienia wola guzkowego szczególnie na obszarach niedoboru jodu. Interesująco przedstawiają 
się również wyniki badań nad wpływem palenia papierosów na ryzyko wystąpienia raka tarczycy. Wiele z nich dowodzi, że u palaczy 
ryzyko raka zróżnicowanego tarczycy jest mniejsze. Ponadto zarówno bierne, jak i czynne palenie papierosów przez kobiety ciężarne 
modyfikuje funkcję gruczołu tarczowego zarówno matki, jak i płodu. W pracy przedstawiono aktualny stan wiedzy dotyczący wpływu 
palenia papierosów na homeostazę hormonalną, procesy autoimmunologiczne oraz choroby tarczycy. W opinii autorów prezentowane 
wyniki badań wymagają rozważnej interpretacji, a niektóre z nich mają stosunkowo słabą siłę dowodu naukowego. Wpływ palenia 
papierosów na patofizjologię tarczycy powinien być przedmiotem dalszych badań. (Endokrynol Pol 2014; 65 (1): 54–62)
Słowa kluczowe: tarczyca; palenie tytoniu; tytoń; nikotyna; hormony tarczycy; TSH; przeciwciała przeciwko receptorowi dla TSH; choroba 
Gravesa i Basedowa; choroba Hashimoto; poporodowe zapalenie tarczycy
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Introduction
Cigarette smoking has a significant impact on human 
health. The total number of smokers is increasing glob-
ally according to data provided by the World Health 
Organization (WHO). Tobacco smoke consists of several 
chemical substances having an impact on the endocrine 
system. This article reviews the influence of cigarette 
smoking on the thyroid gland considering current 
medical knowledge and results of recent studies.
Cigarette smoking is regarded as an independent 
risk factor for Graves’ orbitopathy and multinodular 
goitre in iodine-deficient area. On the other hand, 
smoking may reduce the risk of thyroid cancer [1–3]. 
However, the exact pathophysiological mechanisms 
responsible for these relations are the subject of debate.
The effect of cigarette smoking on thyroid hormones 
and thyroid autoantibodies (Abs) is discussed in the 
first part of this review. The second part focuses on the 
relations between cigarette smoking and thyroid gland 
diseases. The third part sums up the impact of smoke 
exposure on maternal and foetal thyroid gland during 
pregnancy and postpartum period.
Influence of cigarette smoking on serum 
concentration of thyrotropine (TSH), 
thyroxine (T4), triiodothyronine (T3)
Recent studies have found that TSH serum concentra-
tion is lower in smokers [4-8]. Belin et al. conducted 
a population-based cross-sectional study in the United 
States: the Third National Health and Nutrition Ex-
amination Survey (NHANES III). Smoking status was 
estimated using serum cotinine level and self-reported 
questionnaire [8]. The study revealed that active smok-
ers (serum cotinine > 15 ng/mL) had TSH concentra-
tions shifted toward lower values. A similar trend was 
observed among subjects with mild smoke exposure 
(serum cotinine 0.05–15 ng/mL). Mild smoke exposure 
was associated with 40% lower odds of elevated TSH 
levels compared to individuals with undetectable coti-
nine (OR [95% CI] = 0.6 [0.4–0.7]). The trend remained 
after adjustments for age, gender, race/ethnicity and 
iodine status, however it was not statistically significant 
(OR [95% CI] = 0.8 [0.6–1.0]). Moreover, the prevalence 
of TSH elevation above 4.5 mU/L was statistically lower 
in smokers compared to nonsmokers (OR [95% CI] = 
0.6 [0.5–0.6]) after adjustment for confounders. 
Jorde and Sundsfjord performed a cross-sectional 
study and also found that TSH level adjusted for sex, 
age and BMI was lower in smokers (females and males) 
compared to nonsmokers [7]. Moreover, the authors 
evaluated the influence of smoking on TSH concentra-
tion among smokers in relation to use of levothyroxine 
medication. TSH concentration was significantly higher 
in female smokers who used levothyroxine than in 
female smokers who did not use this medication. 
Mehran et al. analysed an Iranian population in 
which adults were classified into ever smokers and 
never smokers according to self-administered ques-
tionnaires [4]. Although the study did not distinguish 
active smoking status from prior smoke exposure, lower 
TSH level was established among ever smoker males 
compared to never smoker males [4].
Some authors evaluated the association between 
dose of smoke exposure and TSH concentration. Belin 
et al. in NHANES III found that the increase in cotinine 
level of 10 ng/mL is associated with a 1.4% decrease of 
OR of having TSH level above 4.5 mU/L after adjust-
ment for age, gender, iodine status and race/ethnicity. 
Moreover, every 10 ng/mL increase in serum cotinine 
was associated with an approximately 2% increased 
odds of having TSH level of 0.1–0.4 mU/L (adjusted 
OR [95% CI] = 1.02 [1.01–1.03]) [8]. Asvold et al. ana-
lysed the correlation between the number of cigarettes 
smoked daily and TSH level [6]. They found that 
heavier smoking was associated with lower TSH con-
centration, but smoking 12 or more cigarettes per day 
did not cause any further decrease of TSH concentration 
[6]. On the contrary, Jorde and Sundsfjord did not find 
a correlation between the number of cigarettes smoked 
daily and TSH serum concentration [7]. In this study, a 
decrease of TSH level was found even in subjects who 
smoked fewer than six cigarettes per day.
The influence of smoking cessation on TSH concen-
tration was also investigated. Asvold et al. suggested 
that smoking may have a reversible effect on thyroid 
gland function. They ascertained that TSH concentra-
tion was similar in former female smokers 5–10 years 
after quitting smoking and in females who have never 
smoked [6]. However, the length of cessation time in 
former male smokers was at least 18 years in order 
to have TSH level similar to males who have never 
smoked [6]. Cho et al. found that TSH level in former 
male smokers was lower than in males who have never 
smoked, but the correlation between the total amount 
of smoked cigarettes (pack-years) and TSH concentra-
tion was not established [5]. When interpreting this 
finding, it is important to consider that the duration of 
quitting smoking in 30% of former smokers was shorter 
than one year. 
An analysis of the relationship between smoking sta-
tus, TSH level and thyroid structure showed interesting 
results. Vejbjerg et al. found a correlation between smok-
ing status and lower TSH only in smokers with multi-
nodular thyroid goitre and diffuse goitre (p < 0.001). 
This was in contrast to smokers with solitary thyroid 
nodule, where no association was reported (p = 0.64) [9]. 
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Moreover, this study found that the influence of ciga-
rette smoking on mean TSH concentration did not differ 
before and after iodisation. 
The influence of smoking on free thyroxine (fT4) 
and free triiodothyronine (fT3) concentrations has been 
found to be more controversial. Jorde and Sundsfjord 
reported higher levels of fT4 and fT3 in smokers com-
pared to nonsmokers [7]. Knudsen et al. performed 
a study in an iodine-deficient region and revealed 
lower TSH concentration and higher fT4 concentration 
in smokers compared to nonsmokers [10]. However, 
there was no impact of smoking status on fT3 level 
[10]. Vejbjerg et al. evaluated the same population in an 
iodine- deficient period and after iodisation of salt. The 
impact of cigarette smoking on the level of TSH and fT4 
did not differ before and after iodisation. Concentra-
tion of fT4 was higher in smokers than in nonsmokers 
regardless of iodine status [9]. The authors also reported 
that before mandatory iodisation of salt there was no 
influence of cigarette smoking on the concentration 
of fT3. However, investigation of an iodine-sufficient 
area revealed that fT3 was higher in smokers. Vejbjerg 
et al. suggested that this finding may be caused by the 
application of different analytic methods for determi-
nation of fT3 concentration before and after iodisation. 
Although most studies showed a stimulatory effect 
of smoking on the thyroid gland, some have revealed 
different findings. Cho et al. did not find a statisti-
cally significant difference in fT4 between smokers 
and nonsmokers [5]. Soldin et al. revealed that both 
active and passive smoke exposure were associated 
with lower levels of T4 and T3 in females compared to 
nonsmokers [11]. 
In conclusion, studies showing an increase of free 
thyroid hormones in smokers are in line with inves-
tigations revealing lower TSH levels in this group of 
patients. 
Influence of cigarette smoking on 
thyroperoxidase antibodies (TPO-Abs), 
thyroglobulin antibodies (Tg-Abs), TSH 
receptor antibodies (TSHR-Abs)
The effect of cigarette smoking on TPO-Abs and 
Tg-Abs is controversial. Some studies have proved that 
cigarette smoking is associated with a lower prevalence 
of TPO-Abs and Tg-Abs [8, 12]. Belin et al. established 
that the increase in cotinine concentration in smokers 
is correlated with a decrease of TPO-Abs and Tg-Abs 
titres. Effraimidis et al. performed a prospective cohort 
study in a population of women who were relatives of 
patients diagnosed with autoimmune thyroid disease. 
The main finding of this study was that smoking ces-
sation increased the risk of occurrence of TPO-Abs 
and/or Tg-Abs [13]. Pedersen et al. reported a nega-
tive association between smoking and the presence of 
Tg-Abs in a survey performed in a moderate and mild 
iodine-deficient population. In this study, a weak asso-
ciation between smoking and TPO-Abs was also found. 
The risk for having thyroid Abs was similar in moderate 
and heavy smokers. Comparison between former and 
never smokers also did not reveal any difference in the 
risk of having thyroid Abs [14]. But Cho et al. failed to 
establish an association between smoking status and 
the level of TPO-Abs [5].
Quadbeck et al. determined that smokers had 
a higher level of TSHR-Abs than nonsmokers [15]. The 
same difference between TSHR-Abs for smokers and 
nonsmokers was assessed after the treatment of Graves’ 
disease with antithyroid drugs (ATDs). 
Influence of cigarette smoking  
on thyroid gland diseases
Graves’ disease (GD) and Graves’  
orbitopathy (GO)
The negative influence of cigarette smoking on GD is 
well established [16, 17]. In a meta-analysis performed 
by Vestergaard, the risk for GD was higher in current 
smokers than in nonsmokers. Another important find-
ing of the meta-analysis was that previous smoking 
did not increase the risk of GD [16]. This particular 
study also revealed that the relationship between 
smoking and GD was similar in iodine-replete and 
iodine-deficient areas. This finding may suggest that 
smoking acts independently of iodine status. Quadbeck 
et al. showed a significantly higher relapse rate of GD 
in smokers compared to nonsmokers [15]. Cigarette 
smoking is considered to be one of the environmental 
risk factors that might impact upon GD development, 
but in some studies there was no difference in GD 
prevalence between smokers and nonsmokers [18]. 
However, one study found a higher proportion of smok-
ers among patients with GD compared to those with 
toxic multinodular goitre and solitary toxic adenoma. 
Lantz et al. analysed three populations of people living 
in an urban area of southern Sweden: people born in 
Sweden, born in Europe but outside Sweden, and born 
outside Europe. Interestingly, the lowest proportion of 
smokers was observed in people born outside Europe 
with the highest share of GD [19]. This finding supports 
the hypothesis that many factors, other than smoking, 
are involved in the development of GD. 
The strong association between cigarette smoking 
and GO is also well established [17, 20, 21]. Cigarette 
smoking increases the risk of GO (OR [95% CI] = 7,7 
[4,3–13,7]) [22]. Childhood GO is also considered to have 
a strong link with tobacco smoke exposure [23]. Some 
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researchers have proved that current smoking status is 
a stronger risk factor than a history of smoking [17]. In 
contrast, many investigators did not find a difference 
in risk of GO occurrence between former and current 
smokers. However, the risk of GO is increased also in 
former smokers compared to never smokers. 
There are still some investigators who did not find 
the association between smoking status, prevalence 
and severity of GD [24, 25]. However, Chen et al. found 
an association between smoking habit and GO [24]. It 
should be considered that these contradictory results 
are derived from investigations carried out on relatively 
small numbers of Asian subjects. Moreover, it has to be 
mentioned that risk of GO due to smoking cigarettes 
was found to be lower in Asians than in Europeans 
[26]. Population-based prospective studies assessing 
the influence of cigarette smoking on both GD and GO 
for Asians are needed to explain those relationships. 
Cigarette smoking is considered to be an independ-
ent risk factor for progression of GO after radioiodine 
(RAI). Smoking increases the risk of development or 
worsening of GO regardless of treatment with RAI or 
ATDs [27]. Quadbeck et al. found that cigarette smok-
ing was associated with a higher risk of relapse of GD 
and GO independently of high TSHR-Abs level [15]. 
Smoking also decreased the initial response to im-
munosuppressive therapy with glucocorticosteroids 
(GCC) or radiotherapy [28, 29]. Eckstein et al. revealed 
better response 1.5–7.5 months after the beginning of 
therapy in nonsmokers but did not find the difference 
in proptosis between smokers and nonsmokers after 
12 months of treatment. However, clinical activity score 
(CAS) and motility estimated 12 months after the be-
ginning of therapy were statistically worse in smokers 
than in nonsmokers. Bartley et al. investigated a group 
of 120 patients with GO and did not find a difference 
in long-term outcome of GO therapy between smokers 
and nonsmokers [30]. 
It seems that smoking has a certain effect on short-
term response to therapy of GO, but the long-term 
influence of smoking is still unclear and requires pro-
spective studies. It is possible that smoking delays the 
response to treatment.
There is still a question whether a smoking dose 
has an influence on GO outcome. There have been 
several studies measuring smoke exposure with dif-
ferent methodological tools. The most frequently as-
sessed parameter was the number of cigarettes smoked 
per day. Pfeilschifter and Ziegler estimated that the 
risk of diplopia and proptosis was statistically higher 
among smokers and it was correlated with smoking 
severity (measured as cigarettes smoked per day and 
total number of cigarettes smoked in a lifetime) [31]. 
Some investigators classify the extent of smoking us-
ing more measurable parameters like cotinine level or 
N-2- hydroxyethylvaline (HEV) level [29, 32]. Eckstein 
et al. established that an initial improvement of clini-
cal symptoms (CAS and motility but not proptosis) in 
patients with GO treated with anti-inflammatory drugs 
was inversely correlated with HEV level.
The mechanism by which cigarette smoking exacer-
bates GO requires further research. Tobacco compounds 
are suspected to act in several possible ways. They may 
have immunomodulatory effect. This hypothesis is 
supported by the results that smoking worsens early 
response to anti-inflammatory therapy of GO with GCC 
or radiotherapy [29]. But cigarette smoking may lead to 
direct damage of thyroid tissue and it could stimulate 
the production of Abs. Similar situation is observed 
when TSHR-Abs level rises after RAI treatment of 
GD, probably due to thyroid damage and release of 
thyrotropine receptors [33]. A case report about GD 
and GO caused by percutaneous ethanol injection 
has been reported [34]. It showed that autoimmune 
response might be triggered by mechanical damage of 
thyroid tissue. Szucs-Farcas et al. performed magnetic 
resonance imaging (MRI) scans of 110 orbits and found 
that the amount of intraorbital connective tissue was 
correlated with cumulative smoking (calculated as the 
total number of cigarettes smoked per day and smok-
ing period in days) for patients with GO. Extraocular 
muscle volumes were not influenced by smoking in 
this study [35].
Hashimoto’s thyroiditis
Fukata et al. found that smoking increased the risk 
of hypothyroidism development among smokers 
with Hashimoto’s thyroiditis [36]. On the other hand, 
a meta-analysis did not confirm an association between 
smoking and hypothyroidism [16]. In sharp contrast to 
these results, other studies have shown that smoking 
may decrease the risk of development of TPO-Abs and 
hypothyroidism [6, 8]. Cho et al. found that subclinical 
hypothyroidism was inversely associated with current 
smoking status in female smokers [5]. This study sug-
gested that the protective effect of smoking on hypo-
thyroidism development is linked with iodine-related 
mechanism rather than direct immunological modu-
lation. However, as mentioned previously, cigarette 
smoking may decrease TPO-Abs titre. Therefore, it may 
be suggested that protective role of smoking on hypo-
thyroidism development is due to the immune system.
The influence of smoking cessation on the risk of 
overt hypothyroidism was also investigated in recent 
studies. In a population-based case-control study 
performed by Carle et al., the risk of hypothyroidism 
was increased within the first two years after quitting 
smoking (OR [95% CI] = 6.53 [3.03–14.10]) [37]. 
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Diffuse goitre, multinodular goitre  
and solitary nodule
It is well established that the prevalence of nontoxic 
goitre is higher among smokers than nonsmokers 
[16, 18]. The influence of smoking is stronger among 
female smokers than male smokers. Goitrogenic effect 
of smoking was more pronounced in iodine-deficient 
areas which may suggest thiocyanate (SCN–) role as 
a competitive inhibitor of iodine uptake [39]. Ittermann 
et al. performed a prospective study in a region with 
improved iodine supply [40]. Cigarette smoking was 
found to have no impact on thyroid growth among 
young subjects (under 40) during a five-year follow-up. 
The association between smoking and thyroid volume 
progression was reported only in subjects aged 60 plus 
presenting goitre in the beginning of the follow-up. This 
was a population of subjects who had been living in an 
iodine-deficient region previously. It is worth stressing 
that subjects who developed goitre during follow-up 
were older, more often former smokers, and reported 
more pack-years than subjects who did not develop 
goitre. Therefore, a declining impact of smoking on 
thyroid volume in iodine-sufficient areas was suggested. 
Vejbjerg et al. also studied the influence of smoking on 
thyroid volume in relation to higher iodine intake in the 
population [9]. The results were compared to findings 
from a cross-sectional study in the same area before 
iodisation of salt. Risk of thyroid enlargement was in-
creased in smokers regardless of iodine status. However, 
the influence of smoking on thyroid volume was lower 
in iodine-sufficient area. A positive association between 
smoking and thyroid volume was reported only among 
women aged 40–45 with low urinary iodine concentra-
tion, which indicates an iodine- dependent mechanism.
Cigarette smoking is regarded as a risk factor for 
multinodular thyroid gland in iodine-deficient regions. 
Knudsen et al. described the prevalence of multi-
nodular goitre as two times higher in smokers than in 
nonsmokers (16.5% v. 7.6%) [41]. In contrast, there was 
no influence of smoking status on prevalence of soli-
tary thyroid nodules. A stronger association between 
smoking and multinodular goitre was seen in areas 
with more pronounced iodine deficiency, however it 
was not statistically significant. On the other hand, 
a study conducted in an iodine-sufficient region revealed 
equal distribution of smokers among the three types of 
hyperthyroidism (GD 24% of hyperthyroid smokers 
(HS), toxic multinodular goitre 21% of HS, and solitary 
toxic adenoma 24% of HS) [42]. According to Vejbjerg et 
al., there was no correlation between smoking and the 
occurrence of multiple thyroid nodules in men after 
mandatory iodisation. This cross-sectional study also 
failed to reveal an association between smoking and 
solitary thyroid nodule regardless of iodine status [9]. 
SCN– is a compound of cigarette smoke considered 
to be a goitrogenic factor. A study conducted in an 
area with significant air pollution as a SCN– source 
suggested that it is an independent cofactor for goitre 
development in smokers and nonsmokers [43]. Thyroid 
volume enlargement and goitre were also associated 
with increased dietary intake of SCN– from cabbage in 
Sicily [44]. However, the influence of cigarette smoking 
on thyroid volume seems to decline due to mandatory 
iodisation. Thus, further studies are required to reveal 
the impact of tobacco smoking on thyroid volume ac-
cording to improved iodine supply.
Thyroid gland cancer
A reduced risk of thyroid gland cancer due to cigarette 
smoking status has been found in several studies [1–3, 45]. 
Mack et al. performed an international pooled analysis 
of 14 case-control studies and found 40% reduction in 
risk of papillary and follicular thyroid cancers among 
current smokers compared to never smokers. Some 
studies established decreased risk of thyroid cancer 
associated with current smoking status compared to 
former tobacco consumption [2, 3]. 
A different pooled analysis of 14 case-control studies 
revealed a decreased risk of medullary thyroid cancer in 
current smokers, with no gender related difference [46]. 
Kabat et al. analysed data concerning smoking 
habits and thyroid cancer prevalence among women 
who participated in a large, multi-centre study: The 
Women’s Health Initiative (WHI) [47]. Current active 
smoking status was associated with reduced risk of all 
thyroid cancers (Hazard Ratio (HR) [95% CI] = 0.54 
[0.29–1.0]) and papillary thyroid cancer (HR [95% CI] = 
= 0.34 [0.15–0.78]). A pooled analysis of five prospective 
studies conducted in the United States revealed that 
current smokers had reduced risk of thyroid cancer (HR 
[95% CI] = 0.68 [0.55–0.85]) compared to never smokers 
[48]. However, some cohort studies did not find influence 
of tobacco smoking on thyroid cancer prevalence [49, 50].
The influence of daily tobacco dose on the reduced 
risk of thyroid cancer remains unclear. Guingard et al. 
did not report any correlation between age at starting 
smoking, daily tobacco consumption, smoking dura-
tion and reduction of the risk of thyroid cancer [51]. 
However, Kitahara et al. found positive correlations 
between smoking intensity, duration, pack-years and 
risk reduction among former and current smokers [48]. 
TSH plays a role in growth and differentiation of 
thyroid cells. Previously discussed decrease of TSH 
concentration in smokers may hypothetically explain 
the reduced risk of differentiated thyroid cancer com-
pared to nonsmokers. The mechanism of suggested 
inverse relationship of cigarette smoking and medullary 
thyroid cancer requires further research.
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Influence of cigarette smoking on maternal 
and foetal thyroid gland function
Thyroid hormones are essential for the development of 
the foetus. Changes in thyroid function are modulated 
by several factors related to physiological pregnancy, 
such as: influence of human chorionic gonadotropin, 
activity of placental deiodinases, increased iodine renal 
clearance and changes in thyroid hormone binding 
protein concentration. The exact influence of cigarette 
smoking on maternal and foetal thyroid function is not 
clearly established. Shields et al. analysed TSH, fT3, fT4 
concentrations and TPO-Abs titre in two independ-
ent cohorts of pregnant women: one during the first 
trimester (n = 1,428), and one during the beginning of 
the third trimester (n = 927). TSH, fT3, fT4 were also 
measured in cord blood of newborns born to women 
from the third trimester cohort [52]. The authors found 
that maternal TSH concentration was lower and ma-
ternal fT3 concentration was higher in smokers than in 
nonsmokers. No association was determined between 
maternal fT4 concentration and cigarette smoking. The 
prevalence of TPO-Abs positive women was similar in 
smokers and in nonsmokers in both cohorts. TPO-Abs 
titre was measured only in the third trimester cohort 
and was higher in smokers. The authors of this study 
also examined the influence of the number of cigarettes 
smoked per day on maternal TSH, fT4, fT3 concentra-
tions: they did not find any dose-related effect. In the 
third trimester cohort, cessation of smoking in the first 
trimester of pregnancy led to reversal of smoking-relat-
ed changes in thyroid hormones. In both cohorts, TSH 
and fT3 concentrations were similar between women 
who stopped smoking during pregnancy and women 
who had never smoked. Concentration of fT4 was lower 
in women who stopped smoking compared to women 
who had never smoked (first trimester cohort). TSH 
concentration measured in cord blood of newborns 
born to mothers who smoked during pregnancy was 
lower than of those born to nonsmokers. No correla-
tions were found for fT4 and fT3. 
A recent study from Finland on 4,837 euthyroid 
mothers showed different results [53]. Smoking before 
pregnancy or during first trimester caused an increase 
in fT3 concentration, but a decrease in fT4 concentra-
tion compared to non-smoking women. Smoking in 
the second trimester caused similar changes, except fT4 
concentration which remained unchanged. All these 
alterations might be explained by smoking-related 
changes in peripheral metabolism of thyroid hormones. 
Interestingly, TSH concentration was similar in smok-
ers and nonsmokers, regardless of pregnancy period. 
Samples taken from this cohort were also assayed for 
Tg-Abs (lower prevalence in smokers) and TPO-Abs 
(similar prevalence in smokers). Based on their results, 
the authors hypothesised that lower fT4 concentration 
in smoking mothers might be a risk factor for hypothy-
roidism in the future. However, this cohort analysed 20 
years later had a similar prevalence of hypothyroidism 
compared to nonsmokers. 
Chen and Kelly showed in a study on thyroid 
function in neonatal rats that maternal nicotine expo-
sure did not alter the total T4 level, T3 uptake and the 
calculated fT4 index in the offspring [54]. The authors 
hypothesised that the smoking-related alterations in 
TSH and thyroid hormones levels might be caused by 
other substances in cigarette smoke, but not the nicotine 
itself. Similar results were presented by Colzani et al. 
who studied the effect of nicotine on thyroid function 
in non-pregnant rats [55]. 
Chanoine et al. investigated the influence of ma-
ternal smoking on neonatal thyroid volume [56]. The 
study was conducted in an area of borderline iodine 
intake (median maternal urinary iodine: 315 nmol/L). 
Authors used cord serum SCN– as an index of maternal 
smoking and found a positive correlation between 
SCN– concentration and neonatal thyroid volume. This 
finding was not accompanied by alterations in TSH, 
fT4 and fT3 levels which remained within the normal 
range in all newborns. 
Postpartum thyroiditis (PPT) is defined as thyroiditis 
diagnosed within 12 months since childbirth. The asso-
ciation of smoking with increased risk of PPT and other 
postpartum autoimmune disorders has been presented 
in some studies [16, 57–59]. The contradictory results 
of other researchers are probably due to differences in 
study design, sample size, and definitions of cigarette 
smoke exposure [60, 61].
Discussion
There is a relatively large amount of data on the influence 
of cigarette smoking on the thyroid gland. This influence 
is exerted through different mechanisms and modified 
by several factors such as age, sex, ethnicity and iodine 
status. Contradictory results of some studies may arise 
from those complex relationships, but also from various 
methodological tools used by investigators.
Many researchers have used self-reported smoking 
status questionnaires. Some investigators did not distin-
guish between former and current smokers. Belin et al. 
defined ‘smoker’ using serum cotinine concentration. 
Eckstein et al. estimated smoking status via determi-
nation of N-2-hydroxyethylvaline (HEV). Laboratory 
parameters enable the avoidance of misclassifying 
passive smokers as nonsmokers. 
Based on this, estimation of smoking status using 
biochemical testing might be especially important for 
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investigations carried out on children and teenagers. In 
those subjects, laboratory measurements are the only 
reliable tool for determination of tobacco smoke expo-
sure. They enable to precisely assess the dose of smoke 
exposure and should be used in further prospective 
studies. Estimating the severity of smoking according 
to the number of cigarettes smoked per day seems to be 
insufficient and can lead to misleading results. 
The results of TSH, fT4 and fT3 evaluation in smok-
ers quoted in our review suggest that the concentration 
of TSH in serum is decreased in most smokers. It should 
be noted that the same authors or others in the same 
time found the concentration of fT4 and fT3 in smok-
ers to be elevated [4–10]. In our opinion, as correlation 
between concentration of TSH and fT4 is generally 
accepted, the decreased concentration of TSH may be 
much more related to elevated fT4 than to smoking 
itself. The problem as to whether the effect of smoking 
primarily affects concentration of thyrotropin or forma-
tion of fT4 requires further study. 
Cigarette smoking may have a deteriorating impact 
on many autoimmune diseases, such as rheumatoid 
arthritis, Crohn’s disease, and systemic lupus erythe-
matosus [62, 63]. In sharp contrast, cigarette smoking 
seems to improve ulcerative colitis and Behçet disease 
[62]. It could be hypothesised that the main influence of 
cigarette smoking on Hashimoto’s thyroiditis and GD 
results from immune modulation. The exact pathogenic 
mechanisms of these autoimmune disorders have not 
been sufficiently revealed. Investigations on the effects 
of cigarette smoking on immunity have shown that both 
the cell-mediated and the humoral immune response 
is affected in smokers. Interestingly, cigarette smoking 
has both pro-inflammatory and immuno-suppressive 
effects. Nicotine, hydroquinone and carbon monoxide 
are the main compounds of cigarette smoke with sug-
gested suppressive influence on the immune system 
[62]. Obviously, the influence of nicotine or other 
cigarette smoke compounds on the immune system is 
regulated by many factors, but cigarette smoke expo-
sure is believed to inhibit Th1 cytokine production and 
may lead to enhancement of Th2 response [62]. Since 
Hashimoto’s thyroiditis is regarded as a predominantly 
Th1 disease, the suppressive effect of cigarette smo-
king on Th1 response may explain the decreased risk 
of this disease among smokers [64, 65]. The increase in 
risk of GD and GO in smokers may be caused by the 
Th2 cytokines involvement and enhancement of Th2 
response, which is also considered as one of the main 
factors in pathogenesis of GD and GO. Cigarette smok-
ing may also increase oxidative stress in patients with 
GO and this might also be responsible for the higher 
risk of GO in smokers. 
In conclusion, since the pathogenesis of HT and GD 
is still uncertain, it is difficult to explain the basis of the 
influence of cigarette smoking on thyroid autoimmun-
ity. On the other hand, experimental investigations 
concerning the influence of cigarette smoke compounds 
on thyroid autoimmunity may provide new insights 
into the pathogenesis of these disorders. 
An inverse relationship between cigarette smoking 
and thyroid cancer risk seems to be well established. 
However, the existing data on the mechanisms of this 
association is definitely insufficient. Among many fac-
tors involved in the pathogenesis of thyroid cancer, 
only a few have been found to be modified by smoking. 
TSH as a major growth factor for thyroid nodules has 
long been hypothesised to play a crucial role in thyroid 
carcinogenesis [66]. Cigarette smoking is associated 
with decreased serum TSH concentration, which may 
limit cancer growth. To date, this is the most convincing 
hypothesis linking cigarette smoking with a decreased 
risk of thyroid cancer. 
It has long been known that the incidence of thyroid 
cancer is significantly higher among women, which 
may be due to the metabolism of oestrogens. There is 
strong evidence that oestrogens may directly stimulate 
thyroid cells, through oestrogen receptors (ORs). The 
action of oestrogens on thyroid cells is rather complex 
and may involve several genomic and non-genomic 
components, with a major effect on cell function 
modulation and proliferation [67]. Smoking has been 
shown to have anti-oestrogenic effect, thus may have 
the potential to inhibit growth of oestrogen- depend-
ent cancers.
Several studies have shown that patients with 
higher BMI tend to suffer from thyroid cancer more 
frequently [68]. This phenomenon might be explained 
by the fact that adipose tissue is an important second-
ary source of circulating oestrogens. Numerous stud-
ies have shown that BMI is lower in smokers than in 
non-smokers and it might be an additional component 
modifying the risk of thyroid cancer development, 
although this has yet to be confirmed [69]. 
Despite opposite action on thyroid cancer develop-
ment, cigarette smoking is one of the major causes of 
carcinogenesis. This action is exerted through direct 
genotoxicity, but also through epigenetic (nongeno-
toxic) effects. Cigarette smoke is a mixture of several 
hundreds of substances, of which more than 60 con-
sidered carcinogenic act on mechanisms involving 
all steps of carcinogenesis [70]. Based on studies on 
smoking-related cancers, many genes and regula-
tory pathways have been discovered to play a role in 
smoking-induced carcinogenesis [71]. Interestingly, 
some of these elements may also be involved in thy-
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roid cancer development. Genetic alterations differ 
according to its histological type (papillary, follicular, 
medullary, anaplastic) and their detailed description 
is not a subject of this review. However, some major 
genetic alterations, common for smoking-related can-
cers and thyroid cancers should be listed here. These 
are mutations in such genes like: BRAF, RAS, PI3K/AKT, 
PTEN, TP53. Nonetheless, mechanisms of acquisition 
and persistence of given mutations may have some 
tissue specificity and probably differ according to the 
organs. The exact aetiology of these mutations in thy-
roid cancer depending on smoking status is unknown 
and definitely deserves further research. 
To summarise, investigations on the influence of 
several compounds of cigarette smoke on the thyroid 
gland may give a better understanding of the results 
from epidemiological studies which frequently provide 
contradictory data. On the other hand, for some thyroid 
diseases there is strong evidence for the effect of smok-
ing. In GD and especially in GO, smoking cessation is 
effective in primary, secondary and tertiary prevention. 
In thyroid gland cancer, cigarette smoking seems to 
have opposite effects. 
However, it should never be considered as a pro-
tective agent in medical practice, because of the huge 
number of deleterious effects on other organs and 
whole systems. Altogether, the possible effects of smok-
ing on thyroid pathophysiology is not fully elucidated. 
Some data suggesting beneficial results of smoking on 
Hashimoto’s thyroiditis or thyroid cancer should be 
considered as requiring further, more comprehensive, 
studies.
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